A detailed history of Apple Watch development; SI-BONE publishes sacroiliac joint dysfunction data;

@FierceMedDev: ICYMI Friday: J&J ordered to hand over $5.6M in vaginal mesh trial. Report | Follow @FierceMedDev

@VarunSaxena2: Four clinical trial patients die in test of Sunshine Heart ventricle assist device. Story | Follow @VarunSaxena2

@EmilyWFierce: Get this week's edition of FierceLifeSci here! | Follow @EmilyWFierce

> SI-BONE has published data showing that its minimally invasive iFuse Implant System improves outcomes for sacroiliac joint dysfunction patients versus nonsurgical management. More

> In advance of the launch of the Apple Watch, which is anticipated in April, The Telegraph has compiled a history of its patents and development milestones. Article

> Fox News works to stir up a furor over the latest technology wave of baby monitoring technology. Story

Biotech News

@FierceBiotech: Baxter and its controversial partner CTI claim a win in PhIII blood cancer study. Report | Follow @FierceBiotech

@JohnCFierce: From the weekend file: UPDATED: Merck to shutter Cubist unit in May, axing most of the 128 R&D staffers. Report | Follow @JohnCFierce

@DamianFierce: Hey @FierceBiotech's podcast is now available on Stitcher. If you know what that means, here you go. | Follow @DamianFierce

> Biopharma's new normal: Constant makeovers leave R&D jobs at permanent risk. Story

> Baxter and its controversial partner CTI claim a win in PhIII blood cancer study. News

> AcelRx hammered (again) after FDA demands a new Zalviso study after all. Article

Pharma News

@FiercePharma: Roche neighbors sue, claiming contamination lowered home prices. More | Follow @FiercePharma

@EricPFierce: ICYMI: MS Pharma in Jordan gets $30M development loan to expand its drug manufacturing. Story | Follow @EricPFierce

@CarlyHFierce: German court deals another EU patent blow to Lilly's blockbuster Alimta. Article | Follow @CarlyHFierce

> GSK sacks 100-plus China workers for misconduct in wake of bribery scandal. News

> Novartis CEO eyes more cost cuts to satisfy margin demands. Story

> Opdivo's survival benefit inspired FDA to act fast on NSCLC approval: Pazdur. More

Biotech IT News

> NIH puts data stitching at top of precision medicine to-do list. More

> Broadly positive reactions roll in for FDA's drug shortages app. Report

> Ubisoft creates therapeutic video game to treat lazy eye. Item

> Intel-GE joint venture teams with Xavier U. to test health tech. Story

> AstraZeneca's rapid-fire IT dealmaking continues with Elixir hookup. Article

CRO News

> Altasciences partners up for early-stage R&D. Article

> Contractor Almac gets into the clinic with a candidate of its own. More

> Icon doubles down on med tech with latest offering. Story

> Patheon snags another CMO amid its global expansion. News

> WuXi eyes major growth in 2015 with plans to spend big. Article

Animal Health News

> Heska scores record 2014 sales on 'more focused' strategy. More

> EMA seeks input on new guidelines to combat antibiotics resistance. Item

> Researchers tap dogs for insights into stopping cancer metastasis. Article

> Future veterinarians go to Congress to discuss student loan debt. Story

> McDonald's ditches antibiotics-raised chicken as legislators launch bill to curb use. Report

Suggested Articles

Qiagen launched a one-stop shop compiling publicly available genomic data, scientific literature and phenotypic information on potential superbugs.

Adaptive Biotechnologies is planning a $200 million IPO to help power its sequencing tests aimed at the body’s immune system and related therapies.

Abbott’s new diabetes test provides A1c results in three minutes, allowing clinicians to develop care plans within a single office visit.